FDA’s Promising New Framework for Rare Genetic Diseases

Read full text Summarise with VIRAT
Authors: Scott Gottlieb, Maarika Kimbrell
Cited by: 0
References: 4

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This JAMA Forum discusses the opportunities and challenges facing US Food and Drug Administration (FDA) new approval paths for individualized therapies to treat rare genetic diseases.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Biomedical Ethics and Regulation Pharmaceutical studies and practices

Publication details

Journal / source
JAMA Health Forum
Volume
7
Issue
3
Pages
e261227–e261227
Publication date
26 March 2026
Language
EN